As of 2025-10-30, the Intrinsic Value of Faron Pharmaceuticals Oy (FARN.L) is -125.62 GBP. This FARN.L valuation is based on the model Peter Lynch Fair Value. With the current market price of 190.00 GBP, the upside of Faron Pharmaceuticals Oy is -166.12%.
Based on its market price of 190.00 GBP and our intrinsic valuation, Faron Pharmaceuticals Oy (FARN.L) is overvalued by 166.12%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -125.62 - -125.62 | -125.62 | -166.12% |
| P/E | (104.01) - (72.36) | (88.56) | -146.6% |
| DDM - Stable | (238.15) - (1,080.39) | (659.27) | -447.0% |
| DDM - Multi | (113.06) - (407.34) | (177.98) | -193.7% |
| Market Cap (mil) | 204.37 |
| Beta | 0.29 |
| Outstanding shares (mil) | 1.08 |
| Enterprise Value (mil) | 212.12 |
| Market risk premium | 5.98% |
| Cost of Equity | 8.74% |
| Cost of Debt | 5.00% |
| WACC | 8.55% |